RNA Interference Induces BRCA1 Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells.

IF 2.4 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Cancer Biotherapy and Radiopharmaceuticals Pub Date : 2024-08-01 Epub Date: 2022-02-18 DOI:10.1089/cbr.2021.0346
Yuebin Shi, Rui Huang, Yong Zhang, Qiang Feng, Xinyan Pan, Li Wang
{"title":"RNA Interference Induces <i>BRCA1</i> Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells.","authors":"Yuebin Shi, Rui Huang, Yong Zhang, Qiang Feng, Xinyan Pan, Li Wang","doi":"10.1089/cbr.2021.0346","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Purpose:</i></b> To investigate the relationship between breast cancer susceptibility gene-1 (<i>BRCA1</i>) gene methylation and the radiosensitivity of breast cancer. <b><i>Materials and Methods:</i></b> The authors studied three breast cancer cell lines: MDA-MB-435, MDA-MB-231, and MCF-7 cells. They constructed five short hairpin RNAs (shRNAs) and five small interfering RNAs to target selected promoter loci and initiate sequence-specific methylation in breast cancer cells. Pyrosequencing was used to analyze the state of DNA methylation. Quantitative real-time polymerase chain reaction was used to detect <i>BRCA1</i> mRNA expression and RNA-directed DNA methylation (RdDM)-related gene expression. Western blotting was performed to analyze BRCA1 protein expression. Colony formation assays and γ-histone H2A foci formation assays were conducted to assess the surviving fraction (SF) and double-strand break (DSB) repair ability of cells after irradiation. <b><i>Results:</i></b> The authors constructed five strains of lentivirus vectors and five plasmid vectors targeting <i>BRCA1</i> promoter region. In MDA-MB-435 cells, lentivirus-mediated RNA interference targeting Site 1 of BRCA1 increased the methylation levels of <i>BRCA1</i> and reduced <i>BRCA1</i> mRNA and protein expression. The SF and the ability to repair DNA DSBs were reduced in the combined LV-BRCA1RNAi-Site 1 infection and irradiation group. <b><i>Conclusions:</i></b> The authors' findings suggest that the shRNA suppressed the expression levels of the <i>BRCA1</i> gene and reduced the SF and DNA repair ability of cells after irradiation through RdDM. In summary, the radiosensitivity of breast cancer cells may correlate with <i>BRCA1</i> methylation. <b><i>Advances in Knowledge:</i></b> The authors first utilized a lentivirus-based shRNA-mediated specific-sequence DNA methylation of the <i>BRCA1</i> gene mediated by RdDM.</p>","PeriodicalId":55277,"journal":{"name":"Cancer Biotherapy and Radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biotherapy and Radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/cbr.2021.0346","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/2/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To investigate the relationship between breast cancer susceptibility gene-1 (BRCA1) gene methylation and the radiosensitivity of breast cancer. Materials and Methods: The authors studied three breast cancer cell lines: MDA-MB-435, MDA-MB-231, and MCF-7 cells. They constructed five short hairpin RNAs (shRNAs) and five small interfering RNAs to target selected promoter loci and initiate sequence-specific methylation in breast cancer cells. Pyrosequencing was used to analyze the state of DNA methylation. Quantitative real-time polymerase chain reaction was used to detect BRCA1 mRNA expression and RNA-directed DNA methylation (RdDM)-related gene expression. Western blotting was performed to analyze BRCA1 protein expression. Colony formation assays and γ-histone H2A foci formation assays were conducted to assess the surviving fraction (SF) and double-strand break (DSB) repair ability of cells after irradiation. Results: The authors constructed five strains of lentivirus vectors and five plasmid vectors targeting BRCA1 promoter region. In MDA-MB-435 cells, lentivirus-mediated RNA interference targeting Site 1 of BRCA1 increased the methylation levels of BRCA1 and reduced BRCA1 mRNA and protein expression. The SF and the ability to repair DNA DSBs were reduced in the combined LV-BRCA1RNAi-Site 1 infection and irradiation group. Conclusions: The authors' findings suggest that the shRNA suppressed the expression levels of the BRCA1 gene and reduced the SF and DNA repair ability of cells after irradiation through RdDM. In summary, the radiosensitivity of breast cancer cells may correlate with BRCA1 methylation. Advances in Knowledge: The authors first utilized a lentivirus-based shRNA-mediated specific-sequence DNA methylation of the BRCA1 gene mediated by RdDM.

RNA 干扰诱导 BRCA1 基因甲基化并提高乳腺癌细胞的放射敏感性
目的:研究乳腺癌易感基因-1(BRCA1)基因甲基化与乳腺癌放射敏感性之间的关系。材料与方法:作者研究了三种乳腺癌细胞系:MDA-MB-435、MDA-MB-231 和 MCF-7 细胞。他们构建了五种短发夹 RNA(shRNA)和五种小干扰 RNA,以选定的启动子位点为靶点,在乳腺癌细胞中启动序列特异性甲基化。热测序被用来分析DNA甲基化的状态。定量实时聚合酶链反应用于检测 BRCA1 mRNA 的表达和 RNA 引导的 DNA 甲基化(RdDM)相关基因的表达。用 Western 印迹法分析 BRCA1 蛋白表达。进行集落形成试验和γ-组蛋白 H2A 病灶形成试验,以评估辐照后细胞的存活率(SF)和双链断裂(DSB)修复能力。结果作者构建了五株慢病毒载体和五种靶向 BRCA1 启动子区域的质粒载体。在 MDA-MB-435 细胞中,慢病毒介导的针对 BRCA1 第 1 位点的 RNA 干扰增加了 BRCA1 的甲基化水平,降低了 BRCA1 mRNA 和蛋白质的表达。在 LV-BRCA1RNAi-Site 1 感染和辐照联合组中,SF 和修复 DNA DSB 的能力降低。结论:作者的研究结果表明,shRNA 通过 RdDM 抑制了 BRCA1 基因的表达水平,并降低了细胞在辐照后的 SF 和 DNA 修复能力。总之,乳腺癌细胞的放射敏感性可能与 BRCA1 甲基化有关。知识的进步:作者首次利用基于慢病毒的 shRNA,通过 RdDM 介导 BRCA1 基因的特异序列 DNA 甲基化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
2.90%
发文量
87
审稿时长
3 months
期刊介绍: Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies. The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信